GE has also signed a separate supply agreement with Rayence for that firm's complementary metal-oxide semiconductor (CMOS) digital detector technology, providing Rayence with a sales channel to the global market.
Upon closure of the mammography deal, the Rayence mammography assets will become part of GE Healthcare's Detection and Guidance Solutions business unit. GE said it intends to continue all local engineering and production in Korea while targeting the global market.
For its part, Rayence plans to invest the proceeds from the sale into the research and development of core parts for x-ray devices, including detectors and the expansion of manufacturing lines, according to CEO James Hyun.
The transaction is subject to customary closing conditions and is expected to close in the third quarter. Financial terms were not disclosed.
Copyright © 2013 AuntMinnie.com